Detection of multiple myositis-specific autoantibodies in unique patients with idiopathic inflammatory myopathy: A single centre-experience and literature review: Systematic review
- PMID: 33831755
- DOI: 10.1016/j.semarthrit.2021.03.012
Detection of multiple myositis-specific autoantibodies in unique patients with idiopathic inflammatory myopathy: A single centre-experience and literature review: Systematic review
Abstract
Introduction: Myositis-specific autoantibodies (MSAs) are thought to be mutually exclusive in patients with idiopathic inflammatory myopathies (IIM) based on studies with immunoprecipitation-based (IP) detection methods. Recently, detection of multiple MSAs in unique patients is increasingly reported, but the extent of this phenomenon remains unclear.
Methods: At our centre, we reviewed results from two line immunoassays and one dot immunoassay in 145 IIM patients and 240 controls for the presence of multiple MSAs. Pubmed and Embase were systematically searched for articles mentioning detection of multiple MSAs in IIM patients, published until February 2019. We assessed the frequency, detection method, the precise combinations and clinical phenotypes of participants with multiple MSAs.
Results: At our centre, detection of multiple MSAs occurred in 3.4-8.3% of patients with IIM, depending on the assay. However, no cases with full concordance across all three assays were identified. Forty-four articles reported detection of multiple MSAs, representing a total of 133 cases, including four patients with a connective tissue disease other than IIM and two healthy controls. In 101 cases all MSAs were detected using only one detection method: 40 cases with IP-based methods (most frequently used technique) and 61 cases with other assay types. In most cases the phenotype of patients with multiple MSAs matched the predicted presentation associated with one MSA and in few cases the phenotype matched with both MSAs.
Conclusion: Detection of multiple MSAs in unique IIM patients is less rare than commonly accepted. Specificity issues of the commercially available multiplex immunoassays may, at least partly, explain the higher frequency compared to IP-based methods. 'True multiple MSA-positive' patients may exist, though they are most likely rare.
Keywords: Autoantibodies; Detection method; Immunoassay; Inflammatory myopathy; Myositis.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Conflicts Interest None
Comment in
-
Considering the level of myositis-specific autoantibodies could improve the precision of multiplex assay : lesson from patients with multiple positive results.Semin Arthritis Rheum. 2022 Feb;52:151871. doi: 10.1016/j.semarthrit.2021.06.011. Epub 2021 Jul 14. Semin Arthritis Rheum. 2022. PMID: 34404513 No abstract available.
Similar articles
-
Line blot immunoassays in idiopathic inflammatory myopathies: retrospective review of diagnostic accuracy and factors predicting true positive results.BMC Rheumatol. 2020 Jul 20;4:28. doi: 10.1186/s41927-020-00132-9. eCollection 2020. BMC Rheumatol. 2020. PMID: 32699830 Free PMC article.
-
Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies.Clin Rheumatol. 2019 Jan;38(1):125-132. doi: 10.1007/s10067-018-4267-z. Epub 2018 Aug 25. Clin Rheumatol. 2019. PMID: 30145635
-
Performance of myositis-specific antibodies detected on myositis line immunoassay to diagnose and sub-classify patients with suspected idiopathic inflammatory myopathy, a retrospective records-based review.Int J Rheum Dis. 2021 Sep;24(9):1167-1175. doi: 10.1111/1756-185X.14174. Epub 2021 Jul 11. Int J Rheum Dis. 2021. PMID: 34250724
-
Narrative review of autoantibodies in idiopathic inflammatory myopathies.Ann Transl Med. 2023 Apr 15;11(7):291. doi: 10.21037/atm-21-475. Epub 2021 Dec 10. Ann Transl Med. 2023. PMID: 37090051 Free PMC article. Review.
-
Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays.Autoimmun Rev. 2019 Mar;18(3):293-305. doi: 10.1016/j.autrev.2018.10.004. Epub 2019 Jan 11. Autoimmun Rev. 2019. PMID: 30639643 Review.
Cited by
-
Positioning of myositis-specific and associated autoantibody (MSA/MAA) testing in disease criteria and routine diagnostic work-up.J Transl Autoimmun. 2022 Feb 11;5:100148. doi: 10.1016/j.jtauto.2022.100148. eCollection 2022. J Transl Autoimmun. 2022. PMID: 35243286 Free PMC article.
-
Comparison of Lineblot and Immunoprecipitation Methods in the Detection of Myositis-Specific and Myositis-Associated Antibodies in Patients with Idiopathic Inflammatory Myopathies: Consistency with Clinical Diagnoses.Diagnostics (Basel). 2024 Sep 30;14(19):2192. doi: 10.3390/diagnostics14192192. Diagnostics (Basel). 2024. PMID: 39410596 Free PMC article.
-
Leflunomide-Induced Immune-Mediated Necrotizing Myopathy in a Patient With Rheumatoid Arthritis: A Case Report.J Investig Med High Impact Case Rep. 2023 Jan-Dec;11:23247096221150636. doi: 10.1177/23247096221150636. J Investig Med High Impact Case Rep. 2023. PMID: 36661254 Free PMC article.
-
Clinical Manifestations and Prognosis of Anti-Signal-Recognition-Particle Myositis.J Clin Neurol. 2024 Jul;20(4):456-458. doi: 10.3988/jcn.2024.0007. J Clin Neurol. 2024. PMID: 38951980 Free PMC article. No abstract available.
-
Performance of cut-offs adjusted with positive control band intensity in line-blot assays for myositis-specific antibodies.Rheumatol Int. 2023 Aug;43(8):1507-1513. doi: 10.1007/s00296-023-05287-5. Epub 2023 Feb 21. Rheumatol Int. 2023. PMID: 36809556
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical